Diplomat Announces 2nd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Diplomat Pharmacy (DPLO) Misses Q2 EPS by 6c; Lowers EPS Outlook
August 6, 2018 4:26 PM EDTDiplomat Pharmacy (NYSE: DPLO) reported Q2 EPS of $0.17, $0.06 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.42 billion.
GUIDANCE:
Diplomat Pharmacy maintains FY2018 revenue of $5.5-5.9 billion, versus the consensus of $5.67... More
